These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 29749519

  • 1. Pulsed electromagnetic fields inhibit osteoclast differentiation in RAW264.7 macrophages via suppression of the protein kinase B/mammalian target of rapamycin signaling pathway.
    Lei Y, Su J, Xu H, Yu Q, Zhao M, Tian J.
    Mol Med Rep; 2018 Jul; 18(1):447-454. PubMed ID: 29749519
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase.
    Glantschnig H, Fisher JE, Wesolowski G, Rodan GA, Reszka AA.
    Cell Death Differ; 2003 Oct; 10(10):1165-77. PubMed ID: 14502240
    [Abstract] [Full Text] [Related]

  • 6. Effects of moderate intensity static magnetic fields on osteoclastic differentiation in mouse bone marrow cells.
    Kim EC, Park J, Noh G, Park SJ, Noh K, Kwon IK, Ahn SJ.
    Bioelectromagnetics; 2018 Jul; 39(5):394-404. PubMed ID: 29709064
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.
    Hong G, Zhou L, Shi X, He W, Wang H, Wei Q, Chen P, Qi L, Tickner J, Lin L, Xu J.
    Int J Mol Sci; 2017 Jan 19; 18(1):. PubMed ID: 28106828
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inactivation of Regulatory-associated Protein of mTOR (Raptor)/Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in Osteoclasts Increases Bone Mass by Inhibiting Osteoclast Differentiation in Mice.
    Dai Q, Xie F, Han Y, Ma X, Zhou S, Jiang L, Zou W, Wang J.
    J Biol Chem; 2017 Jan 06; 292(1):196-204. PubMed ID: 27879318
    [Abstract] [Full Text] [Related]

  • 15. Nicotinamide phosphoribosyltransferase inhibits receptor activator of nuclear factor-κB ligand-induced osteoclast differentiation in vitro.
    Baek JM, Ahn SJ, Cheon YH, Lee MS, Oh J, Kim JY.
    Mol Med Rep; 2017 Feb 06; 15(2):784-792. PubMed ID: 28035412
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. WSS25, a sulfated polysaccharide, inhibits RANKL-induced mouse osteoclast formation by blocking SMAD/ID1 signaling.
    Chen C, Qin Y, Fang JP, Ni XY, Yao J, Wang HY, Ding K.
    Acta Pharmacol Sin; 2015 Sep 06; 36(9):1053-64. PubMed ID: 26299951
    [Abstract] [Full Text] [Related]

  • 18. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P, Tu Q, Chen J.
    J Bone Miner Res; 2005 Sep 06; 20(9):1669-79. PubMed ID: 16059638
    [Abstract] [Full Text] [Related]

  • 19. Docosahexaenoic acid signaling attenuates the proliferation and differentiation of bone marrow-derived osteoclast precursors and promotes apoptosis in mature osteoclasts.
    Kim HJ, Ohk B, Yoon HJ, Kang WY, Seong SJ, Kim SY, Yoon YR.
    Cell Signal; 2017 Jan 06; 29():226-232. PubMed ID: 27836739
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.